143 related articles for article (PubMed ID: 12975722)
41. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
42. Switching from prescription to over the counter.
Reynolds T
Ann Intern Med; 2002 Jan; 136(2):177-80. PubMed ID: 11790082
[No Abstract] [Full Text] [Related]
43. Real-World Evidence, Public Participation, and the FDA.
Schwartz JL
Hastings Cent Rep; 2017 Nov; 47(6):7-8. PubMed ID: 29171057
[TBL] [Abstract][Full Text] [Related]
44. Over-the-counter medications and self-care.
Lowe NK; Ryan-Wenger NM
Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
[TBL] [Abstract][Full Text] [Related]
45. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
[TBL] [Abstract][Full Text] [Related]
46. [Financial restrictions in health care systems could affect treatment quality of GERD-patients].
Gillessen A; Schöffel L; Naumburger A
Z Gastroenterol; 2006 May; 44(5):379-85. PubMed ID: 16688654
[TBL] [Abstract][Full Text] [Related]
47. Formulary management of proton pump inhibitors.
Byrne MF; Murray FE
Pharmacoeconomics; 1999 Sep; 16(3):225-46. PubMed ID: 10558037
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
49. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
Sullivan PW; Follin SL; Nichol MB
Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671
[TBL] [Abstract][Full Text] [Related]
50. The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.
Unge P; Jönsson B; Stålhammar NO
Pharmacoeconomics; 1995 Nov; 8(5):410-27. PubMed ID: 10160075
[TBL] [Abstract][Full Text] [Related]
51. Locally produced drugs need quality control.
Qureshi H; Ahmed W; Mehdi I
J Pak Med Assoc; 1998 Jul; 48(7):226-7. PubMed ID: 10067033
[No Abstract] [Full Text] [Related]
52. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
Fed Regist; 1998 Apr; 63(77):19799-802. PubMed ID: 10179316
[TBL] [Abstract][Full Text] [Related]
53. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
54. Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default.
Kilbride M; Joffe S; Lynch HF
Hastings Cent Rep; 2020 Nov; 50(6):15-26. PubMed ID: 33315251
[TBL] [Abstract][Full Text] [Related]
55. Esomeprazole: update and clinical review.
Baker DE
Rev Gastroenterol Disord; 2002; 2(4):189-99. PubMed ID: 12481170
[TBL] [Abstract][Full Text] [Related]
56. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
Allen N; Walker SR; Liberti L; Salek S
Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
[TBL] [Abstract][Full Text] [Related]
57. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
58. Improving the PPI sample for prescription pharmaceuticals.
Kelly GG
Mon Labor Rev; 1997 Oct; 120(10):10-7. PubMed ID: 10176326
[No Abstract] [Full Text] [Related]
59. Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.
El-Sayed A; Boraie NA; Ismail FA; El-Khordagui LK; Khalil SA
East Mediterr Health J; 2007; 13(6):1427-37. PubMed ID: 18341192
[TBL] [Abstract][Full Text] [Related]
60. Over-the-counter omeprazole (prilosec OTC).
Med Lett Drugs Ther; 2003 Aug; 45(1162):61-2. PubMed ID: 12888738
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
